Ingenuity pathway analysis (IPA) confirmed the putative involvement of genes that regulate EMT (HDAC3, ERBB2, SMAD7) [8, 28, 43] or drive tumor progression and metastatic dissemination (i.e., TP53, TNF, ESR1, HGF, PI3K) in BC. This evidence concerns the gene TP53 and breast cancer.